CANNARA BIOTECH INC (LOVE.CA) Stock News

Canada - TSX-V:LOVE - CA13765U2002 - Common Stock

1.58 CAD

-0.02 (-1.25%)

Last: 11/19/2025, 7:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

LOVE.CA Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Inc. annoncera ses résultats financiers pour le quatrième trimestre de l'exercice 2025 et l'exercice 2025 le 24 novembre 2025 et fournit une mise à jour du conseil d’administration

3 days ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Inc. to Announce Fiscal Q4 2025 and Fiscal Year 2025 Financial Results on November 24, 2025 and Provides Board Update

a month ago - By: Cannara Biotech (Québec) Inc.

Cannara obtient l’admissibilité à la DTC afin de faciliter l’accès des investisseurs américains et renforce son bilan grâce à la conversion de sa dette en actions

a month ago - By: Cannara Biotech (Québec) Inc.

Cannara Announces DTC Eligibility to Facilitate U.S. Investor Access and Strengthens Balance Sheet through completion of Debt-to-Equity Conversion

2 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Announces Proposed Settlement of Convertible Debenture via Share Issuance

2 months ago - By: Cannara Biotech (Québec) Inc.

Cannara annonce le règlement proposé de débentures convertibles par le biais d’une émission d’actions

2 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Announces Proposed Settlement of Convertible Debenture via Share Issuance

3 months ago - By: Cannara Biotech (Québec) Inc.

Cannara annonce l’octroi d’options d’achat d’actions et d’unités d’actions restreintes (RSU)

3 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Announces Grant of Options and RSUs

3 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Announces Grant of Options and RSUs

3 months ago - By: Cannara Biotech (Québec) Inc.

Cannara annonce la modification et l’augmentation de la facilité de crédit accordée par BMO afin de soutenir l’expansion de ses installations à Valleyfield

3 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Announces Amendment and Upsize of BMO Credit Facility to Support Facility Expansion at Valleyfield

3 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Announces Amendment and Upsize of BMO Credit Facility to Support Facility Expansion at Valleyfield

3 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech renforce sa flexibilité financière grâce à la vente stratégique d'actifs

3 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Enhances Financial Flexibility Through Strategic Asset Sale

3 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech Enhances Financial Flexibility Through Strategic Asset Sale

4 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech enregistre son chiffre d’affaires et sa rentabilité les plus élevés depuis sa création au troisième trimestre de l’exercice 2025

4 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Delivers Highest Revenue and Profitability Since Inception in Fiscal Q3 2025

4 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech Delivers Highest Revenue and Profitability Since Inception in Fiscal Q3 2025

4 months ago - By: Cannara Biotech (Québec) Inc.

Cannara obtient 5 inscriptions clés dans la nouvelle catégorie de cartouches de vapotage de la SQDC, y compris des cartouches de vapotage à base de rosine vivante à venir

4 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Secures 5 Key Listings in Québec’s New Vape Cartridge Category Including to be Released Live Rosin Vapes

4 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Secures 5 Key Listings in Québec’s New Vape Cartridge Category Including to be Released Live Rosin Vapes

4 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Inc. annoncera ses résultats financiers du troisième trimestre de l'exercice 2025 le 28 juillet 2025

4 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Inc. to Announce Fiscal Q3 2025 Financial Results on July 28, 2025

4 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech Inc. to Announce Fiscal Q3 2025 Financial Results on July 28, 2025

5 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech organise une webdiffusion pour les investisseurs le 25 juin 2025

5 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech to Host Investor Webcast on June 25th, 2025

5 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech to Host Investor Webcast on June 25th, 2025

5 months ago - By: Cannara Biotech (Québec) Inc.

Cannara réduit le coût de sa dette en abaissant son taux d’intérêt et en remboursant partiellement sa débenture convertible ; remporte le prix de la marque de l’année 2025

5 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Reduces Cost of Debt with Lower Interest Rate and Partial Debenture Repayment; Wins 2025 Brand of the Year

7 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech affiche des résultats record au deuxième trimestre et accélère son expansion nationale

7 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates

7 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates

5 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Reduces Cost of Debt with Lower Interest Rate and Partial Debenture Repayment; Wins 2025 Brand of the Year

7 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Inc. annoncera ses résultats financiers pour le deuxième trimestre de l'exercice 2025 le 28 avril 2025

7 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025

7 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025

8 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech annonce la nomination de Justin Cohen au conseil d’administration

8 months ago - By: Cannara Biotech (Québec) Inc.

Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors

8 months ago - By: Cannara Biotech (Québec) Inc. - Mentions: -

Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors